BeiGene (HKG:6160, SHA:688235) granted share options and restricted share units to its employees and directors under its 2016 share option and incentive plan, according to a Friday filing with the Hong Kong stock exchange.
The biopharmaceutical company granted 22,713 American depositary shares to 12 employees.The options are equivalent to 295,269 underlying shares, and will vest in 10 years, the filing said.
It also granted 90,542 restricted share units in ADSs to 223 recipients, equivalent to 1,177,046 underlying shares, according to the filing.
Price (HKD): $147.70, Change: $+7.0, Percent Change: +4.98%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。